Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PLCG1 antisense RNA 1 (PLCG1-AS1) is a long noncoding RNA transcribed from the antisense strand at the PLCG1 gene locus. It does not code for a protein and is distinct from the well-characterized protein enzyme Phospholipase C gamma 1 (PLCG1). There is minimal experimental data or functional annotation for PLCG1-AS1 in the biomedical literature. Its aliases (e.g., TOP1-AS1) may create confusion, but PLCG1-AS1 should not be equated with the protein-coding PLCG1 gene, a critical enzyme in signal transduction and cancer. At present, PLCG1-AS1 is not a recognized therapeutic target, nor are there known drugs or biomarkers associated with it. Notes on nomenclature: - The canonical abbreviation and full name should follow: PLCG1 antisense RNA 1 (PLCG1-AS1). - Commonly encountered aliases (such as TOP1-AS1) often conflate this lncRNA with unrelated entities, further emphasizing the need for careful distinction in structured data records. - Several database entries (e.g., NCBI Gene, Ensembl) confirm the classification of PLCG1-AS1 as a long noncoding RNA, not a protein-coding gene, enzyme, or receptor. If a conventional drug discovery or pharmacological target is required, users should refer to the protein Phospholipase C gamma 1 (PLCG1), not PLCG1-AS1. If interested in the general regulatory or biomarker role of noncoding RNAs, PLCG1-AS1 may be a candidate for future research, but it currently lacks robust functional annotation.
Not applicable; no drugs targeting PLCG1-AS1 directly are known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PLCG1 antisense RNA 1 (PLCG1-AS1).